Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Norbert Vey; Marie Anne Hospital; Aude Collignon; Yves Collette; Daniel Birnbaum; Aude Charbonnier; Bilal Mohty; Evelyne d'Incan; Jerome Rey; Remy Castellano; Camille Montersino; Max Chaffanet; Nadine Carbuccia; Jose Adelaide; Benjamin Bouchacourt; Arnaud Guille

doi:10.1182/blood-2018-99-119263

Journal articles

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Norbert Vey ¹ Marie Anne Hospital Aude Collignon Yves Collette Daniel Birnbaum ¹ Aude Charbonnier Bilal Mohty Evelyne d'Incan Jerome Rey Remy Castellano ¹ Camille Montersino ¹ Max Chaffanet ¹ Nadine Carbuccia ¹ Jose Adelaide ¹ Benjamin Bouchacourt Arnaud Guille ¹

1 CRCM - Centre de Recherche en Cancérologie de Marseille

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-02143630
Contributor : Ghislain Bidaut <>
Submitted on : Wednesday, May 29, 2019 - 2:51:15 PM
Last modification on : Monday, June 1, 2020 - 1:16:02 AM

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Identifiers

Collections

Citation

Export

Metrics

71

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Identifiers

Collections

Citation

Export

Share

Metrics

71